# European Study Evaluating the EMBLOK Embolic Protection System During TAVR

> **NCT03130491** · NA · COMPLETED · sponsor: **Emblok, Inc.** · enrollment: 28 (actual)

## Conditions studied

- Aortic Valve Disease

## Interventions

- **PROCEDURE:** Transcatheter Aortic Valve Replacement (TAVR)
- **DEVICE:** EMBLOK filter

## Key facts

- **NCT ID:** NCT03130491
- **Lead sponsor:** Emblok, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-08
- **Primary completion:** 2021-11-01
- **Final completion:** 2022-01-28
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130491, "European Study Evaluating the EMBLOK Embolic Protection System During TAVR". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03130491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*